Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hypertension, Pulmonary | 13 | 2019 | 970 | 2.98 | Why? |
| Stroke Volume | 16 | 2018 | 2153 | 2.77 | Why? |
| Heart Failure | 28 | 2021 | 6638 | 2.77 | Why? |
| Exercise Test | 15 | 2021 | 911 | 2.56 | Why? |
| Oxygen Consumption | 10 | 2021 | 711 | 1.69 | Why? |
| Pulmonary Circulation | 6 | 2018 | 207 | 1.65 | Why? |
| Ventricular Function, Right | 5 | 2018 | 388 | 1.32 | Why? |
| Exercise Tolerance | 7 | 2021 | 634 | 1.32 | Why? |
| Echocardiography, Stress | 3 | 2018 | 65 | 0.86 | Why? |
| Vascular Resistance | 3 | 2019 | 148 | 0.76 | Why? |
| Pulmonary Artery | 2 | 2017 | 803 | 0.75 | Why? |
| Pulmonary Ventilation | 2 | 2019 | 152 | 0.74 | Why? |
| Hemodynamics | 6 | 2018 | 1562 | 0.73 | Why? |
| Physical Exertion | 2 | 2017 | 176 | 0.71 | Why? |
| Exercise Therapy | 2 | 2019 | 976 | 0.66 | Why? |
| Sildenafil Citrate | 1 | 2017 | 66 | 0.65 | Why? |
| Arterial Pressure | 2 | 2017 | 208 | 0.64 | Why? |
| Ventricular Function, Left | 4 | 2018 | 1555 | 0.63 | Why? |
| Atrial Function, Left | 1 | 2016 | 82 | 0.62 | Why? |
| Myocardial Contraction | 1 | 2017 | 123 | 0.61 | Why? |
| Mitral Valve Insufficiency | 2 | 2018 | 302 | 0.61 | Why? |
| Echocardiography, Doppler | 4 | 2018 | 269 | 0.60 | Why? |
| Ventricular Dysfunction, Right | 3 | 2017 | 639 | 0.59 | Why? |
| Carbon Dioxide | 2 | 2017 | 917 | 0.51 | Why? |
| Rest | 2 | 2017 | 188 | 0.50 | Why? |
| Death, Sudden, Cardiac | 3 | 2018 | 522 | 0.49 | Why? |
| Exercise | 8 | 2021 | 6771 | 0.44 | Why? |
| Heart Ventricles | 3 | 2019 | 1139 | 0.44 | Why? |
| Occupational Health Services | 1 | 2013 | 219 | 0.41 | Why? |
| Preventive Health Services | 1 | 2013 | 501 | 0.35 | Why? |
| Risk Reduction Behavior | 1 | 2013 | 946 | 0.31 | Why? |
| Oxygen | 3 | 2018 | 3715 | 0.30 | Why? |
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 2 | 2017 | 24 | 0.29 | Why? |
| Cardiovascular Diseases | 4 | 2020 | 11497 | 0.29 | Why? |
| Renin-Angiotensin System | 1 | 2020 | 3661 | 0.28 | Why? |
| Prognosis | 14 | 2021 | 32490 | 0.27 | Why? |
| Phosphodiesterase 5 Inhibitors | 2 | 2017 | 104 | 0.26 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.26 | Why? |
| Endothelium, Vascular | 1 | 2014 | 1751 | 0.25 | Why? |
| Catheter Ablation | 2 | 2018 | 438 | 0.25 | Why? |
| Antihypertensive Agents | 1 | 2014 | 1962 | 0.24 | Why? |
| Heart Rate | 4 | 2018 | 1527 | 0.23 | Why? |
| Workplace | 1 | 2013 | 2075 | 0.22 | Why? |
| Atrial Fibrillation | 3 | 2021 | 2320 | 0.21 | Why? |
| Follow-Up Studies | 12 | 2020 | 17020 | 0.21 | Why? |
| Heart Failure, Diastolic | 1 | 2019 | 21 | 0.21 | Why? |
| Health Promotion | 1 | 2013 | 2020 | 0.20 | Why? |
| Predictive Value of Tests | 6 | 2018 | 9537 | 0.20 | Why? |
| Electrocardiography | 2 | 2017 | 3957 | 0.19 | Why? |
| Obesity, Abdominal | 1 | 2021 | 167 | 0.19 | Why? |
| Ventricular Dysfunction, Left | 2 | 2019 | 993 | 0.19 | Why? |
| Body Surface Potential Mapping | 1 | 2018 | 20 | 0.19 | Why? |
| Humans | 53 | 2021 | 930598 | 0.18 | Why? |
| Familial Primary Pulmonary Hypertension | 1 | 2018 | 68 | 0.18 | Why? |
| Phenotype | 3 | 2021 | 4037 | 0.18 | Why? |
| Mitral Valve Annuloplasty | 1 | 2018 | 35 | 0.18 | Why? |
| Nitroglycerin | 1 | 2017 | 39 | 0.18 | Why? |
| Adrenergic beta-Antagonists | 2 | 2018 | 465 | 0.17 | Why? |
| Adrenocorticotropic Hormone | 1 | 2017 | 107 | 0.17 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2019 | 6166 | 0.17 | Why? |
| Propanolamines | 1 | 2017 | 47 | 0.17 | Why? |
| Occupational Health | 1 | 2013 | 3965 | 0.17 | Why? |
| Sulfones | 1 | 2017 | 66 | 0.16 | Why? |
| Vasodilator Agents | 2 | 2017 | 344 | 0.16 | Why? |
| Cyclophosphamide | 1 | 2018 | 387 | 0.16 | Why? |
| Suture Techniques | 1 | 2018 | 138 | 0.16 | Why? |
| Carbazoles | 1 | 2017 | 120 | 0.15 | Why? |
| Ventricular Fibrillation | 1 | 2017 | 126 | 0.15 | Why? |
| Brugada Syndrome | 1 | 2017 | 98 | 0.15 | Why? |
| Surgery, Computer-Assisted | 1 | 2018 | 183 | 0.15 | Why? |
| Vasodilation | 1 | 2017 | 258 | 0.15 | Why? |
| Blood Vessels | 1 | 2017 | 228 | 0.14 | Why? |
| Troponin | 1 | 2021 | 1058 | 0.14 | Why? |
| Cardiorespiratory Fitness | 1 | 2019 | 313 | 0.14 | Why? |
| Cardiomyopathy, Hypertrophic | 1 | 2017 | 193 | 0.14 | Why? |
| Physical Fitness | 1 | 2018 | 334 | 0.14 | Why? |
| Chicago | 1 | 2017 | 653 | 0.14 | Why? |
| Mitral Valve | 1 | 2018 | 342 | 0.13 | Why? |
| Tachycardia, Ventricular | 1 | 2017 | 251 | 0.13 | Why? |
| Coronary Stenosis | 1 | 2017 | 273 | 0.13 | Why? |
| Analysis of Variance | 1 | 2017 | 950 | 0.13 | Why? |
| Statistics, Nonparametric | 1 | 2017 | 1008 | 0.13 | Why? |
| Cardiology | 2 | 2019 | 2873 | 0.13 | Why? |
| Anaerobic Threshold | 1 | 2013 | 42 | 0.13 | Why? |
| Severity of Illness Index | 8 | 2021 | 48226 | 0.12 | Why? |
| Cardiac Catheterization | 2 | 2017 | 882 | 0.12 | Why? |
| Time Factors | 7 | 2021 | 31397 | 0.12 | Why? |
| Health Status | 2 | 2019 | 3259 | 0.12 | Why? |
| Imaging, Three-Dimensional | 1 | 2018 | 680 | 0.12 | Why? |
| Kinetics | 2 | 2018 | 3238 | 0.12 | Why? |
| Prospective Studies | 11 | 2018 | 43301 | 0.12 | Why? |
| Coronary Artery Disease | 2 | 2017 | 2570 | 0.12 | Why? |
| Heart Function Tests | 1 | 2012 | 101 | 0.12 | Why? |
| Male | 29 | 2021 | 367725 | 0.11 | Why? |
| Comorbidity | 5 | 2020 | 34796 | 0.11 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2017 | 881 | 0.11 | Why? |
| Treatment Outcome | 9 | 2019 | 51732 | 0.11 | Why? |
| Middle Aged | 23 | 2021 | 270681 | 0.11 | Why? |
| Recovery of Function | 2 | 2021 | 2461 | 0.10 | Why? |
| Heart Valve Prosthesis Implantation | 1 | 2017 | 552 | 0.10 | Why? |
| Italy | 9 | 2021 | 38444 | 0.10 | Why? |
| Aged | 18 | 2021 | 215776 | 0.10 | Why? |
| Multiple Organ Failure | 1 | 2020 | 1724 | 0.10 | Why? |
| Natriuretic Peptide, Brain | 1 | 2017 | 1215 | 0.10 | Why? |
| Kidney Function Tests | 1 | 2012 | 520 | 0.10 | Why? |
| European Union | 1 | 2013 | 565 | 0.10 | Why? |
| Adaptation, Physiological | 1 | 2013 | 359 | 0.10 | Why? |
| Hospital Mortality | 7 | 2021 | 22087 | 0.10 | Why? |
| Female | 25 | 2021 | 380317 | 0.10 | Why? |
| Risk Factors | 8 | 2021 | 71621 | 0.10 | Why? |
| Cardiotonic Agents | 1 | 2011 | 418 | 0.09 | Why? |
| Athletes | 1 | 2017 | 1047 | 0.09 | Why? |
| Survival Rate | 4 | 2017 | 9206 | 0.09 | Why? |
| Risk Assessment | 4 | 2018 | 25439 | 0.09 | Why? |
| Consensus | 2 | 2019 | 6345 | 0.08 | Why? |
| Program Development | 1 | 2013 | 1089 | 0.08 | Why? |
| Hydrocortisone | 1 | 2017 | 1790 | 0.08 | Why? |
| Peptide Fragments | 1 | 2017 | 2075 | 0.08 | Why? |
| Action Potentials | 2 | 2018 | 368 | 0.08 | Why? |
| Retrospective Studies | 9 | 2021 | 105322 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2019 | 3755 | 0.07 | Why? |
| Disease Progression | 3 | 2020 | 13580 | 0.07 | Why? |
| Myocarditis | 1 | 2021 | 2731 | 0.07 | Why? |
| Risk | 1 | 2017 | 5288 | 0.07 | Why? |
| Glucocorticoids | 1 | 2021 | 4431 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.07 | Why? |
| Forecasting | 1 | 2019 | 4492 | 0.07 | Why? |
| Dose-Response Relationship, Drug | 3 | 2018 | 3776 | 0.07 | Why? |
| Echocardiography | 4 | 2019 | 3661 | 0.07 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.07 | Why? |
| Dyspnea | 1 | 2017 | 3847 | 0.06 | Why? |
| Reproducibility of Results | 2 | 2017 | 11304 | 0.06 | Why? |
| Sepsis | 1 | 2020 | 3517 | 0.06 | Why? |
| Practice Guidelines as Topic | 3 | 2019 | 15421 | 0.06 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.06 | Why? |
| Algorithms | 1 | 2019 | 7346 | 0.06 | Why? |
| Cohort Studies | 4 | 2021 | 36005 | 0.06 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.05 | Why? |
| Morbidity | 2 | 2017 | 1426 | 0.05 | Why? |
| Societies, Medical | 1 | 2017 | 6907 | 0.05 | Why? |
| Heart Diseases | 1 | 2018 | 3503 | 0.05 | Why? |
| Europe | 2 | 2017 | 12702 | 0.05 | Why? |
| Guideline Adherence | 1 | 2013 | 2309 | 0.05 | Why? |
| Waist Circumference | 1 | 2021 | 199 | 0.05 | Why? |
| Signal Transduction | 2 | 2014 | 7207 | 0.05 | Why? |
| Partial Pressure | 1 | 2020 | 279 | 0.05 | Why? |
| Myocardium | 1 | 2011 | 2323 | 0.05 | Why? |
| Evidence-Based Medicine | 1 | 2013 | 3228 | 0.05 | Why? |
| Natriuretic Peptides | 1 | 2019 | 66 | 0.05 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.05 | Why? |
| Pulmonary Wedge Pressure | 1 | 2019 | 53 | 0.05 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.05 | Why? |
| X-Rays | 1 | 2021 | 492 | 0.05 | Why? |
| Ajmaline | 1 | 2017 | 4 | 0.04 | Why? |
| Multivariate Analysis | 2 | 2020 | 5440 | 0.04 | Why? |
| Fluoroscopy | 1 | 2018 | 140 | 0.04 | Why? |
| Phosphorus Isotopes | 1 | 2017 | 2 | 0.04 | Why? |
| Case-Control Studies | 1 | 2016 | 17671 | 0.04 | Why? |
| Coronary Angiography | 2 | 2017 | 2275 | 0.04 | Why? |
| Cardiac-Gated Imaging Techniques | 1 | 2017 | 25 | 0.04 | Why? |
| Causality | 1 | 2021 | 857 | 0.04 | Why? |
| Diastole | 1 | 2017 | 168 | 0.04 | Why? |
| Blood Gas Analysis | 1 | 2020 | 893 | 0.04 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.04 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.04 | Why? |
| Finland | 1 | 2018 | 671 | 0.04 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.04 | Why? |
| Death | 1 | 2018 | 334 | 0.04 | Why? |
| Troponin T | 1 | 2020 | 771 | 0.04 | Why? |
| Electric Countershock | 1 | 2017 | 284 | 0.03 | Why? |
| Protective Factors | 1 | 2020 | 1720 | 0.03 | Why? |
| Anti-Arrhythmia Agents | 1 | 2017 | 325 | 0.03 | Why? |
| Cause of Death | 2 | 2018 | 4823 | 0.03 | Why? |
| Electrophysiologic Techniques, Cardiac | 1 | 2017 | 396 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.03 | Why? |
| Polycythemia | 1 | 2011 | 19 | 0.03 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.03 | Why? |
| Nitric Oxide Synthase Type III | 1 | 2011 | 87 | 0.03 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2019 | 1755 | 0.03 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.03 | Why? |
| Cell Hypoxia | 1 | 2011 | 141 | 0.03 | Why? |
| Cardiomegaly | 1 | 2011 | 96 | 0.03 | Why? |
| Defibrillators, Implantable | 1 | 2017 | 624 | 0.03 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 372 | 0.02 | Why? |
| Propensity Score | 1 | 2018 | 2690 | 0.02 | Why? |
| Survivors | 1 | 2021 | 2619 | 0.02 | Why? |
| Heart-Assist Devices | 1 | 2017 | 812 | 0.02 | Why? |
| Rats, Sprague-Dawley | 1 | 2011 | 987 | 0.02 | Why? |
| Hemorrhage | 1 | 2020 | 3013 | 0.02 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| Lung | 1 | 2017 | 31049 | 0.02 | Why? |
| Body Mass Index | 1 | 2021 | 4306 | 0.02 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.02 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.02 | Why? |
| Adult | 4 | 2021 | 244371 | 0.02 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.02 | Why? |
| Disease-Free Survival | 1 | 2012 | 1654 | 0.02 | Why? |
| Delivery of Health Care | 1 | 2013 | 15909 | 0.02 | Why? |
| Heart Transplantation | 1 | 2017 | 1293 | 0.02 | Why? |
| ROC Curve | 1 | 2019 | 6024 | 0.02 | Why? |
| Chronic Disease | 1 | 2020 | 5139 | 0.02 | Why? |
| Body Weight | 1 | 2011 | 1074 | 0.02 | Why? |
| Nitric Oxide | 1 | 2011 | 769 | 0.02 | Why? |
| Rats | 1 | 2011 | 2764 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.02 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.01 | Why? |
| Apoptosis | 1 | 2011 | 2335 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2019 | 10649 | 0.01 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Myocardial Infarction | 1 | 2011 | 3361 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.01 | Why? |
| Pandemics | 1 | 2020 | 389249 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.00 | Why? |
| Animals | 1 | 2011 | 78931 | 0.00 | Why? |
Guazzi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(225)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(109)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_